Category: 3. Business

  • Early-stage economic analysis is increasingly valuable for ACCC merger notifications

    Early-stage economic analysis is increasingly valuable for ACCC merger notifications

    The changes to Australia’s merger notification regime substantially expand the scope for early-stage economic analysis to support more effective and efficient filings.

    The changes to Australia’s merger notification regime substantially expand the scope for early-stage economic analysis to support more effective and efficient filings for merging parties and their legal advisers. Economic analysis can help determine whether filings are necessary, that filings contain only the required level of detail, and that the economic data and analysis required for filings is complete, accurate, and helpful to the Australian Competition and Consumer Commission (ACCC).

    In this brief, Mark Chicu, Nikhil Gupta, Kostis Hatzitaskos, Avigail Kifer, and Andrew Swan identify areas where early-stage economic analysis is likely to be particularly valuable in navigating the new notification process.

    Continue Reading

  • Shionogi Presents Real-World and Surveillance Data Reinforcing Role of Cefiderocol Across Range of Patient Populations and Difficult-to-Treat Infections| SHIONOGI

    Antimicrobial Resistance

    AMR is a major health burden that urgently needs to be addressed.11 Globally, in 2021, there were 1.14 million deaths attributable to bacterial AMR.13 Infections caused by carbapenem-resistant Gram-negative bacteria are often associated with a high mortality rate.14 If no action is taken, drug-resistant pathogens could cause more than 39 million deaths over the next 25 years.13

     

    About Shionogi in AMR

    Shionogi has a strong heritage in the field of anti-infectives and has been developing antimicrobial therapies for more than 60 years. Shionogi is proud to be one of the few large pharmaceutical companies that continues to focus on R&D in anti-infectives.

     

    About Cefiderocol

    In the U.S., cefiderocol is commercially available under the brand name Fetroja® and is indicated in patients 18 years of age or older for the treatment of hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia and complicated urinary tract infections caused by certain susceptible Gram-negative microorganisms.6 In Europe, cefiderocol is commercially available under the brand name Fetcroja® for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options.15 In Japan, cefiderocol is commercially available under the brand name Fetroja® and received manufacturing and marketing approval from the Ministry of Health, Labour and Welfare for various infections caused by strains resistant to carbapenem antibiotics among sensitive strains of Escherichia coli, Citrobacter species, Klebsiella pneumoniae, Enterobacter species, Serratia marcescens, Proteus species, Morganella morganii, Pseudomonas aeruginosa, Burkholderia species, Stenotrophomonas maltophilia, and Acinetobacter species.

     

    U.S. INDICATIONS

    Fetroja® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.

     

    Fetroja is indicated in patients 18 years of age or older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by the following susceptible Gram-negative microorganisms: Acinetobacter baumannii complex, Escherichia coli, Enterobacter cloacae complex, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Serratia marcescens.

     

    USAGE

    To reduce the development of drug-resistant bacteria and maintain the effectiveness of Fetroja and other antibacterial drugs, Fetroja should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

     

    IMPORTANT SAFETY INFORMATION

    CONTRAINDICATIONS

    Fetroja is contraindicated in patients with a known history of severe hypersensitivity to cefiderocol or other beta-lactam antibacterial drugs, or any other component of Fetroja.

     

    WARNINGS AND PRECAUTIONS

    Increase in All-Cause Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacterial Infections

    An increase in 28-day all-cause mortality was observed in Fetroja-treated nosocomial pneumonia, bloodstream infections, or sepsis patients compared to those treated with best available therapy (BAT) in a clinical study (NCT02714595). Most BAT regimens contained colistin. All-cause mortality remained higher in patients treated with Fetroja than in patients treated with BAT through Day 49.

     

    Generally, deaths were in patients with infections caused by Gram-negative organisms, including non-fermenters such as Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa, and were the result of worsening or complications of infection, or underlying comorbidities. The cause of the increase in mortality has not been established. Closely monitor the clinical response to therapy in patients with cUTI and HABP/VABP.

     

    Hypersensitivity Reactions

    Serious and occasionally fatal hypersensitivity (anaphylactic) reactions and serious skin reactions have been reported in patients receiving beta-lactam antibacterial drugs. Hypersensitivity was observed with Fetroja. Before Fetroja is instituted, inquire about previous hypersensitivity to cephalosporins, penicillins, or other beta-lactam drugs. If an allergic reaction occurs, discontinue Fetroja.

     

    Clostridioides difficile-associated Diarrhea (CDAD)

    CDAD has been reported with nearly all systemic antibacterial agents, including Fetroja. Careful medical history is necessary because CDAD has been reported to occur more than 2 months after the administration of antibacterial agents. If CDAD is suspected or confirmed, antibacterial drugs not directed against C. difficile may need to be discontinued.

     

    Seizures and Other Central Nervous System (CNS) Adverse Reactions

    Cephalosporins, including Fetroja, have been implicated in triggering CNS adverse reactions such as seizures. Encephalopathy, coma, asterixis, and neuromuscular excitability have been reported with cephalosporins, particularly in patients with a history of epilepsy and/or when recommended dosages of cephalosporins were exceeded due to renal impairment. Adjust Fetroja dosing based on creatinine clearance. If focal tremors or seizures occur, evaluate patients to determine whether Fetroja should be discontinued.

     

    Development of Drug-Resistant Bacteria

    Prescribing Fetroja in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.

     

    ADVERSE REACTIONS

    The most common adverse reactions occurring in ≥2% of patients receiving Fetroja in the cUTI trial were: diarrhea (4%), infusion site reactions (4%), constipation (3%), rash (3%), candidiasis (2%), cough (2%), elevations in liver tests (2%), headache (2%), hypokalemia (2%), nausea (2%), and vomiting (2%). The most common adverse reactions occurring in ≥4% of patients receiving Fetroja in the HABP/VABP trial were: elevations in liver tests (16%), hypokalemia (11%), diarrhea (9%), hypomagnesemia (5%), and atrial fibrillation (5%).

     

    Please click here for Full U.S. Prescribing Information for Fetroja® (cefiderocol).

     

    Forward-Looking Statements 

    This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, lack of availability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. 

     

    For Further Information, Contact:

    SHIONOGI Website Inquiry Form: https://www.shionogi.com/global/en/contact.html

    U.S. Media: ShionogiCommunications@shionogi.com

    Shionogi Europe Press Office: pressoffice@shionogi.eu

    Continue Reading

  • Japan parliamentary vote, Australia rare earth shares rise

    Japan parliamentary vote, Australia rare earth shares rise

    TOKYO, JAPAN – JULY 27: Pedestrians and shoppers walk through the Akihabara area on July 27, 2023 in Tokyo, Japan. Japan’s core consumer price index climbed by 3.3% in June, outpacing the US figure for the first time in eight years as the Bank of Japan holds its monetary policy meeting on July 27 and 28. (Photo by Tomohiro Ohsumi/Getty Images)

    Tomohiro Ohsumi | Getty Images News | Getty Images

    Japan’s benchmark Nikkei 225 rose more than 1% to a fresh record at 49,739.76, after closing at an all-time high Monday. The Topix also added 0.48% to hit a record high.

    Broader Asia-Pacific markets also opened higher, tracking Wall Street gains led by a rally in Apple shares.

    Investors await Japan’s parliamentary vote, which is likely to see Sanae Takaichi become the country’s next prime minister, after the right-wing opposition Japan Innovation Party said Monday it was ready to back her premiership.

    Australia’s ASX/S&P 200 rose 0.50%. Shares of the country’s rare earth companies rose after Prime Minister Anthony Albanese and U.S. President Donald Trump signed a critical minerals agreement Tuesday, aimed at countering China’s dominance.

    Australia’s Lynas Rare Earths added 3.8%, Iluka Resources jumped nearly 6%, Pilbara Minerals rose 4.7%. VHM skyrocketed over 30%, while Northern Minerals soared nearly 15%.

    South Korea’s Kospi index jumped 1.57%, while the small-cap Kosdaq gained 0.52%.

    Futures for Hong Kong’s Hang Seng Index pointed to a higher open, trading at 26,232, against the index’s previous close of 25,858.83.

    Indian markets are closed for a holiday.

    U.S. equity futures were little changed in early Asian hours, ahead of a busy earnings week from big-name companies and inflation data.

    Overnight, the three key benchmarks in the U.S. rose on a rally in Apple shares after Loop Capital upgraded it to buy from hold.

     The Dow Jones Industrial Average closed 515.97 points, or 1.12%, higher at 46,706.58. The S&P 500 also climbed 1.07% to settle at 6,735.13, while the Nasdaq Composite advanced 1.37% to settle at 22,990.54.

    — CNBC’s Sean Conlon and Pia Singh contributed to this report.

    Continue Reading

  • Venture Global ready to introduce natural gas into final part of Plaquemines LNG plant, filing shows – Reuters

    1. Venture Global ready to introduce natural gas into final part of Plaquemines LNG plant, filing shows  Reuters
    2. LNG Producer Faces Lawsuits Over Alleged Contract Breaches  Crude Oil Prices Today | OilPrice.com
    3. Fresh fight brewing between Venture Global and long-term customers  Upstream Online
    4. Pressure Mounts Against Venture Global to Start Commercial Service on Time at Plaquemines LNG  Natural Gas Intelligence
    5. Venture Global is facing new LNG contract scrutiny in Louisiana  10/12 Industry Report

    Continue Reading

  • DuPont Schedules Third Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., Oct. 20, 2025 – DuPont (NYSE: DD) will release its third quarter financial results at 6:00 a.m. ET on Thursday, November 6, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day.

    The event will be webcast live and can be accessed on DuPont’s Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.       

    The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046.

    DuPont will reflect the previously announced divestiture of its Aramids business as discontinued operations beginning with third quarter 2025 reporting and will reflect its electronics business, Qnity, as discontinued operations beginning in fourth quarter 2025 reporting following the intended separation of Qnity on November 1, 2025.

    Qnity expects to provide a business update on a separate conference call to be announced at a later date.

     

    About DuPont

    DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

    Continue Reading

  • VR Resources Announces $1.5M Brokered Private Placement Led by Centurion One Capital, Concurrent Share Consolidation, Management Change, and Start-Up of Drill Planning for its New Boston Tungsten-Molybdenum-Copper-Silver porphyry project in Nevada

    VR Resources Announces $1.5M Brokered Private Placement Led by Centurion One Capital, Concurrent Share Consolidation, Management Change, and Start-Up of Drill Planning for its New Boston Tungsten-Molybdenum-Copper-Silver porphyry project in Nevada

    VR Resources Ltd.

    VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) — VR Resources Limited (“VR” or the “Company”, TSXV: VRR) is pleased to announce that it has entered into an agreement with Centurion One Capital Corp. (the “Lead Agent”) as lead agent and sole bookrunner in connection with a brokered private placement. The Company initially plans to raise up to $1.5M (the “Offering“) through the sale of up to 15M units (“Units“) at a post-Consolidation issue price of $0.10 per Unit (the “Issue Price”), on a commercially reasonable efforts basis. Each Unit shall consist of one common share in the capital of the Company (each, a “Share”) and one Share purchase warrant (each, a “Warrant”). Each full Warrant shall entitle the holder thereof to purchase one Share (a “Warrant Share”) at a post-Consolidation price of $0.16 (the “Exercise Price”) for a period of 36 months from the Closing Date (as defined below).

    Use of Proceeds – Planned Exploration, Nevada.
    Use of proceeds of the Offering will be used for upcoming exploration planned at its New Boston tungsten-moly-copper-silver porphyry project and Bonita copper-gold porphyry project in Nevada, and for general working capital purposes.

    • Preparation and submission of drill permit for New Boston property: W-Mo-Cu-Ag target at Jeep Mine;

    • Scoping and execution of drill contract for New Boston property;

    • Execution of contract for completion of 3D-arrary DCIP geophysical survey at Bonita project: copper-gold porphyry stock target at Copper Queen

    It is anticipated that certain insiders of the Company, the Lead Agent and certain affiliates may acquire Units in the Offering in amounts up to approximately 50% of the Offering. Any participation by insiders in the Offering will constitute a “related party transaction” as defined under Multilateral Instrument 61101 Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The Company expects such participation will be exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the Units subscribed for by the insiders, nor the consideration for the Units paid by such insiders, is expected to exceed 25% of the Company’s market capitalization.

    In connection with the Offering, a commission will be payable to the Lead Agent of 8% of the aggregate cash proceeds received from the sale of the Offered Securities (the “Cash Commission”) and a number of warrants (the “Broker Warrants”) equal to 8% of the aggregate number of Units issued under the Offering in accordance with the policies of the TSX Venture Exchange (the “Exchange”).

    The Offering is expected to close on or around November 14, 2025, or such other date as agreed upon between the Company and the Lead Agent (the “Closing Date”) and the Offering is subject to certain conditions, including, but not limited to, the receipt of all necessary approvals including the approval of the Exchange and the completion of the Consolidation (as defined below). The securities to be issued under the Offering will have a hold period of four months and one day from the Closing Date.

    The Units to be issued under the Offering will be offered by way of private placement in each of the provinces of British Columbia, Alberta and Ontario, in the United States pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), and in jurisdictions outside of Canada and the United States mutually agreed by the Company and the Lead Agent provided it is understood that no prospectus filing, registration or comparable obligation arises in such other jurisdiction.

    This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the U.S. Securities Act or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

    Consolidation

    The Company further announces that it will undergo a consolidation of its issued and outstanding common shares at a ratio of five (5) pre-consolidation common shares to one (1) post-consolidation common share (the “Consolidation”), subject to approval of the Exchange and confirmation that the Offering will complete. Closing of the Offering will be subject to the prior implementation of the Consolidation. The Company currently has 133,443,467 shares issued and outstanding, and it is anticipated that immediately following the Consolidation, excluding Shares to be issued in connection with the Offering, the Company will have approximately 26,688,695 shares issued and outstanding, prior to rounding of fractional Shares. If approved by the TSXV, the Consolidation will occur immediately prior to the closing of the Offering.

    The Issue Price, Exercise Price and securities issuable pursuant to the Offering reflect the prior implementation of the Consolidation and are all disclosed herein on a post-Consolidation basis.

    Any fractional interest in Shares resulting from the Consolidation will be rounded down to the nearest whole Share. Registered shareholders will receive a letter of transmittal from the Company’s transfer agent with information on how to replace their old share certificates with the new share certificates. Brokerage firms will handle the replacement of share certificates on behalf of their shareholders’ accounts.

    Management Change

    The Company further announces that Justin Daley has tendered his resignation as Chief Executive Officer and President of the Company, effective October 20, 2025. The Company thanks Mr. Daley for his contributions to the Company, and wishes him well in his future endeavours. The Board of Directors has appointed Founder and Chairman, Dr. Michael H. Gunning, as President and CEO.

    ON BEHALF OF THE BOARD OF DIRECTORS

    Dr. Michael H. Gunning
    Chairman

    For general information please use the following:

    Website:
    Email:
    Phone:

    www.vrr.ca
    info@vrr.ca
    778-731-9292


    ABOUT
    VR RESOURCES LTD.

    VR is an established junior exploration company based in Vancouver. VR evaluates, explores and advances opportunities in copper, gold and critical metals in Nevada, USA, and Ontario, Canada. VR applies modern exploration technologies, in-house experience, and expertise in greenfields exploration to large-footprint systems in underexplored areas/districts. The foundation of VR is the proven track record of its Board in early-stage exploration, discovery and M&A. VR owns its projects outright and evaluates new opportunities on an ongoing basis, whether by staking or acquisition.

    ABOUT CENTURION ONE CAPITAL

    Centurion One Capital’s mission is to ignite the world’s most visionary entrepreneurs to conquer the greatest challenges of tomorrow, fueling their ambitions with transformative capital, unparalleled expertise, and a global network of influential connections. Every interaction is guided by our core values of respect, integrity, commitment, excellence in execution, and uncompromising performance. We make principal investments, drawing on the time-honored principles of merchant banking, where aligned incentives forge enduring partnerships. Centurion One Capital: A superior approach to investment banking.

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:

    This news release contains statements that constitute “forward-looking statements”. Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or that events or conditions “will,” “would,” “may,” “could” or “should” occur. Forward-looking statements in this document include statements concerning the details of the Offering, Consolidation, TSXV approvals, use of proceeds, and all other statements that are not statements of historical fact.

    Although the Company believes the forward-looking information contained in this news release is reasonable based on information available on the date hereof, by their nature, forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Examples of such assumptions, risks and uncertainties include, without limitation, assumptions, risks and uncertainties associated with: general economic conditions; adverse industry events; future legislative and regulatory developments in the mining sector; the Company’s ability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; mining industry and markets in Canada; the ability of the Company to implement its business strategies; competition; and other assumptions, risks and uncertainties.

    The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable laws.

    Trading in the securities of the Company should be considered highly speculative. All of the Company’s public disclosure filings may be accessed via www.sedarplus.ca and readers are urged to review them.

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    Continue Reading

  • Notable Threat Updates and Looking Ahead

    Notable Threat Updates and Looking Ahead

    We recently published an Insights piece “The Golden Scale: Bling Libra and the Evolving Extortion Economy,” which primarily focused on the Salesforce data theft extortion activity. This was associated with the cybercriminal syndicate known as Scattered LAPSUS$ Hunters. Since early October 2025, we have observed several notable developments within a Telegram channel (SLSH 6.0 part 3) used by the threat actors. This activity may provide a glimpse into how the group plans to operate in the foreseeable future. We’re providing these insights so that organizations can better prepare for and defend against this evolving threat activity.

    Fallout From the Extortion Deadline

    As noted in our previous Insights piece, Scattered LAPSUS$ Hunters listed the deadline for impacted organizations to make a ransom payment as 11:59 PM ET on Oct. 10, 2025. Since that time, news reports have indicated that the threat actors have leaked stolen data allegedly belonging to six companies. These companies operate across the aviation, energy and retail sectors. The leaked data allegedly includes various types of personally identifiable information (PII) such as names, dates of birth, email addresses, phone numbers and frequent flyer numbers.

    Unit 42 recently tried to access the data leak site (DLS) associated with the threat actors, and noticed the website had what appeared to be a defacement message posted (see Figure 1). As a result, we were unable to determine if any victim data was still listed.

    Figure 1. Screenshot of message posted to Bling Libra’s latest DLS as of Oct. 17, 2025. Source: Scattered LAPSUS$ Hunters’ DLS.

    On Oct. 11, 2025, a day after the posted deadline and the release of data for the six organizations referenced above, the threat actors stated that “nothing else will be leaked.” The meaning of “the things we have cannot be leaked for obvious reasons” is unclear (see Figure 2). These “obvious reasons” could mean increased attention and action from law enforcement due to who owns the data or its type.

    Telegram screenshot reads: "A lot of people are asking what else will be leaked. Nothing else will be leaked. Everything that was leaked was leaked, we have nothing else to leak and obviously the things we have cannot be leaked for obvious reasons. :D
    Figure 2. Screenshot of Telegram post to SLSH 6.0 part 3 channel on Oct. 11, 2025. Source: Telegram.

    As shown below in Figure 3, the threat actors appear to potentially be stepping away from any activities until the beginning of next year. A post after this one states “I promise you, you WILL feel our wrath.”

    Telegram screenshot with a statement from the threat actors on their continuous operations targeting global corporations and critical infrastructure, and insisting they are not criminals but businessmen.
    Figure 3. Screenshot of Telegram post to SLSH 6.0 part 3 channel on Oct. 11, 2025. Source: Telegram.

    Extortion-as-a-Service Program Advertisement

    On Oct. 10, 2025, shortly prior to their self-imposed deadline, the threat actors formally alluded to the launch of their extortion-as-a-service (EaaS) program as shown in Figure 4. They claim this EaaS program will be similar to a typical ransomware-as-a-service (RaaS) program with a clear difference: no file encryption. As noted in my previous Insights piece, one likely factor for this shift is to potentially fly under the radar of law enforcement attention. This could be motivated by their focus on disrupting ransomware operations in recent years.

    Telegram screenshot announcing the launch of a new EaaS (Extortion-as-a-Service), detailing features such as anonymity and professional negotiation support, with further details to be released soon.
    Figure 4. Screenshot of Telegram post to SLSH 6.0 part 3 channel on Oct. 10, 2025. Source: Telegram.

    Renewed Insider Access Recruitment

    On Oct. 5, 2025, the threat actors posted an advertisement seeking insider access at organizations across a variety of industries, as seen in Figure 5.

    As also noted by ReliaQuest on their X account, the threat actors state their primary interest is in acquiring access to call centers, gaming companies, hosting providers, software-as-a-service (SaaS) and telecom organizations. These organizations would be based in countries such as the U.S., UK, Australia, Canada and France.

    Telegram screenshot that includes information on rules, IA rates, employee or insider recruitment, and regions of focus.
    Figure 5. Screenshot of Telegram post to SLSH 6.0 part 3 channel on Oct. 5, 2025 Source: Telegram.

    Threat actors affiliated with “The Com” have previously advertised interest in partnering with insiders at targets of interest to them. This was reported in our May 2025 update on Muddled Libra (aka Scattered Spider).

    Potential Emergence of New Ransomware

    On Oct. 4, 2025, the threat actors claimed to be developing a new form of ransomware named “SHINYSP1D3R” as noted in Figures 6 and 7. These posts appear to be related to observations previously noted by Falconfeeds in August 2025. It is currently unclear if the aforementioned ransomware is still under development or simply a false claim.

    Telegram screenshot: "It's time to make it clear to certain entities what real extortion looks like." The rest of the text lists other cybercrime groups and asks the readers to stay tuned on what's new.
    Figure 6. Screenshot of Telegram posts to SLSH 6.0 part 3 channel on Oct. 4, 2025. Source: Telegram.
    Telegram screenshot that says what is coming next is the GTA 6 of ransomware.
    Figure 7. Screenshot of Telegram posts to SLSH 6.0 part 3 channel on Oct. 4, 2025. Source: Telegram.

    What Comes Next — and What I Recommend You Do

    Given that the clearnet version of Scattered LAPSUS$ Hunters’ newly launched DLS is unavailable at this time, it is unclear if any of the victims listed on the site made a ransom payment to the threat actors.

    Additionally, it remains relatively uncertain if the EaaS program advertised by the threat actors will be as lucrative of a business model as they likely hoped it would be. Given that the advertisement specifically cites the removal of any file encryption in comparison to a traditional RaaS program, organizations may be less willing to make a ransom payment considering the potential lack of operational disruption.

    Finally, it is not evident why the threat actors would potentially be interested in operating both an EaaS and a RaaS program, other than attempting to diversify their revenue streams. This is certainly something Unit 42 will continue to monitor going forward.

    As noted in our previous Insights piece, the theft and leakage of PII, including loyalty program details (e.g., frequent flyer numbers) from some victim organizations (specifically those in hospitality) could enable cybercriminals to conduct identity theft and other types of fraud, including fueling the growth of fraudulent travel agencies advertised across underground cybercrime forums and Telegram channels.

    Given the rise of RaaS programs in recent years, many organizations have developed incident response playbooks specifically to prepare for a ransomware event in terms of operational disruption. I believe it is now time for organizations to create similar playbooks for the growing threat of EaaS programs, specifically to prepare for the reputational risks associated with such events. This should include having third-party experts on standby via retainer to assist with potential negotiations, verification of stolen data and other related actions.

    If your organization has been threatened with data theft extortion by Scattered Lapsus$ Hunters or other cybercriminals, the Unit 42 Incident Response team is here and ready to support with either a suspected compromise or to reduce the risk via a proactive threat assessment.

    Continue Reading

  • The impact of fintech on lending

    Technology – especially AI – is disrupting the world of finance (see overviews in Duffie et al. 2022, Foucault et al. 2025, and Vives 2019). Lending is no exception: machine learning and large datasets are successfully used for credit assessment. Fintech has enabled efficiency gains, such as improved loan screening, monitoring, and processing, and has fostered financial inclusion among underserved populations and in less developed countries.

    At the same time, it raises concerns about financial stability, privacy, and discrimination. Digital technologies enable improved customer segmentation, which not only facilitates personalised services but also allows for finer price discrimination. The empirical evidence on fintech’s impact is mixed regarding loan pricing, substitutability or complementarity of fintech and bank credit, loan default, and data sharing.

    Empirical studies differ on whether default or delinquency rates are higher for fintech-originated loans than for bank-originated loans. While some report higher default rates (Di Maggio and Yao 2021), others report lower (Fuster et al. 2019), and still others find no significant difference (Buchak et al. 2018). Similarly, open banking initiatives increase the likelihood that SMEs form new lending relationships with non-bank lenders and reduce their interest payments. Still, they do not necessarily improve financial inclusion (Babina et al. 2024). However, in Germany (Nam 2023) and India (Alok et al. 2024), open banking has improved credit access on both extensive and intensive margins without increasing risk. In the US, California’s Consumer Privacy Act strengthened fintechs’ screening capabilities relative to banks and enabled more personalised mortgage pricing, ultimately reducing loan rates and improving financial inclusion (Doerr et al. 2023).

    An analytical framework

    In Vives and Ye (2025a, 2025b), my co-author and I present an analytical framework that incorporates key differences between fintech firms and incumbent banks, explains the mixed empirical findings in the literature, and delivers a welfare analysis. The framework introduces a taxonomy of how fintech affects frictions in the lending market. We find that fintech’s impact on competition and welfare hinges on its effect on the differentiation between financial intermediaries and the efficiency gap between them. Primary factors influencing market performance include the level of bank concentration, the intensity of competition among fintechs, the potential for price discrimination, the size of the unbanked population, and the convenience offered by fintechs.

    We consider a spatial oligopolistic competition model in which lenders (banks and fintechs) compete to provide loans to entrepreneurs. The framework captures key differences between fintechs and banks. For example, banks have more financial data and soft information (with relationship lending) than fintechs, but the latter have better information-processing technology and conversion of soft into hard information (with the digital footprint) and lower distance friction with borrowers. This distance can be physical or in terms of expertise; greater distance between a lender and borrower increases the cost of monitoring (or screening).

    Furthermore, banks have lower funding costs, and fintechs have higher convenience benefits. Fintechs also have greater price flexibility for technological and regulatory reasons, which gives them a competitive advantage. In the extreme, banks are differentiated by expertise (location), but fintechs are not; fintechs can price discriminate, whereas banks cannot. In our model, endogenous entrepreneur participation occurs at each location, and entrepreneurial projects require monitoring (screening) to enhance project returns (Vives and Ye 2025b) or to mitigate a moral hazard problem faced by entrepreneurs (Vives and Ye 2025a).

    The type of fintech advancement matters

    A key insight from Vives and Ye (2025a) is that we should distinguish between general advances in fintech that reduce the distance between lenders and borrowers and those that do not. General improvements in information collection and processing, such as enhanced data storage, computing power, or desktop software, do not necessarily reduce distance friction. Technologies that lower the effective distance between lenders and borrowers include improved internet connectivity, video conferencing, remote learning tools, AI, and advanced search engines, which enable lenders to expand their domain expertise and serve distant borrowers more effectively. Big data, together with machine learning, can improve both types of capabilities.

    If fintech does reduce the distance friction, lenders’ differentiation will decrease and competition intensity will increase, decreasing their profits and monitoring incentives. The effect is more pronounced when the entrepreneurs’ moral hazard problem is more severe. The impact on entrepreneurs’ investment and total welfare is hump-shaped. Those effects are not present when fintech progress does not affect the distance between lenders and borrowers.

    Bank and fintech competition

    In Vives and Ye (2025b), we assume that banks are differentiated by expertise (located in a circle) but fintechs are not (located in the virtual middle). We find that (1) fintech entry can be blockaded, remain as a potential threat, or materialise depending on fintechs’ monitoring efficiency, (2) fintech lending can substitute or complement bank lending depending on whether pre-entry banks competed or not, and (3) fintech entry and loan volume is higher when bank concentration is higher.

    Furthermore, if banks cannot price discriminate, a fintech with no advantage in terms of monitoring efficiency or funding costs can enter the lending market. If banks and fintechs have similar funding costs, for entrepreneurs with similar characteristics, banks’ loan rates and monitoring are higher than those of fintechs (and fintech borrowers are more likely to default). The latter result will change if fintechs have significantly higher funding costs than banks. If fintechs have a significant advantage in convenience, they will likely charge higher prices, while banks will conduct more thorough monitoring. Therefore, differences in funding costs, convenience benefits, and abilities to price discriminate may explain the variety of empirical results on loan defaults by banks and fintechs.

    Fintech entry may decrease entrepreneurs’ investment if competition within fintechs is not sufficiently intense. An intermediate level of competition intensity among fintechs is needed to ensure a welfare increase following fintech entry, to balance the incentives of borrowers and lenders.

    However, if banks can also discriminate, fintechs need an advantage in monitoring (or funding costs, although this is less probable) to penetrate the market. Finally, the threat or actual entry of fintechs can induce bank exit or restructuring, potentially reducing the intensity of lending competition and investment, but generating a welfare-improving option value effect.

    Policy implications

    We can derive some policy implications from the analysis. We know that price discrimination is a competitive weapon, but it will not necessarily be welfare optimal unless it extends the market. This is so also in our modelling. Socially optimal loan rates strike a balance between the incentives of entrepreneurs and intermediaries to exert effort, thereby mitigating moral hazard, encouraging entrepreneur participation in the market, and enhancing lenders’ monitoring or screening effort.

    However, this balance typically cannot be obtained from lender competition with location-based discrimination. For example, with endogenous entrepreneur participation at any location, a bank should charge (from a welfare perspective) higher rates for distant locations (since monitoring is more costly and distant locations generate less surplus). In contrast, price-discriminating banks will do the opposite in equilibrium to meet the competition. However, allowing banks to discriminate when fintechs price discriminate improves welfare when there is little inter-fintech competition.

    Regarding data sharing, we find that a policy (e.g. open banking) that benefits fintechs must be complemented by an appropriate degree of inter-fintech competition. Otherwise, the policy may backfire, and a leading fintech may gain a monopoly position in a market segment. Differences in the degree of competition may explain the differences in the empirical results in the impact of open banking.

    In summary, levelling the playing field (in terms of lenders’ ability to price discriminate and access to information) is a good policy aimed at achieving a degree of competition that induces a division of rents, thereby balancing the incentives of different market participants to maximise welfare. This degree of competition must be sufficient to prevent monopoly positions in market segments, while also ensuring that both lenders and borrowers have enough stake in the game.

    References

    Alok, S, P Ghosh, N Kulkarni, and M Puri (2024), “Open banking and digital payments: Implications for credit access”, working paper.

    Babina, T, S A Bahaj, G Buchak, F De Marco, A K Foulis, W Gornall, F Mazzola, and T Yu (2024), “Customer data access and fintech entry: Early evidence from open banking”, working paper.

    Buchak, G, G Matvos, T Piskorski, and A Seru (2018), “Fintech, regulatory arbitrage, and the rise of shadow banks”, Journal of Financial Economics 130: 453–83.

    Di Maggio, M, and V Yao (2021), “FinTech borrowers: Lax screening or cream skimming?”, The Review of Financial Studies 34: 4565–618.

    Doerr, S, L Gambacorta, L Guiso, and M Sanchez del Villar (2023), “Privacy regulation and fintech lending”, working paper.

    Duffie, D, T Foucault, L Veldkamp, and X Vives (2022), Technology and finance, The Future of Banking 4, CEPR Press.

    Foucault, T, L Gambacorta, W Jiang and X Vives (2025), Artificial intelligence in finance, The Future of Banking 7, CEPR Press.

    Fuster, A, M Plosser, P Schnabl, and J Vickery (2019), “The role of technology in mortgage lending”, The Review of Financial Studies 32: 1854–99.

    Nam, R J (2023), “Open Banking and Customer Data Sharing: Implications for Fintech Borrowers”, SAFE Working Paper No. 364.

    Vives, X (2019), “Digital disruption in banking”, Annual Review of Financial Economics 11: 243–72.

    Vives, X, and Z Ye (2025a), “Information technology and lender competition”, Journal of Financial Economics 163: 103957.

    Vives, X, and Z Ye (2025b), “Fintech entry, lending market competition, and welfare”, Journal of Financial Economics 168: 104040.

    Continue Reading

  • Platform Insights: LinkedIn 2025 | WARC

    We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

    Continue Reading

  • Survey on Assessment of Health and Environmental Hazards and Risks of Surface-Treated Nanomaterials Will Close October 31, 2025

    Survey on Assessment of Health and Environmental Hazards and Risks of Surface-Treated Nanomaterials Will Close October 31, 2025

    The European Union (EU) Observatory for Nanomaterials (EUON) has contracted the Nanotechnology Industries Association (NIA) and Yordas Group to undertake a study on the assessment of health and environmental hazards and risks of surface-treated nanomaterials. The aim of the study is to review and collect scientific information and data on how surface treatment can affect the properties of nanomaterials and potentially have an impact of their fate and potential risks. The study includes a market survey to understand:

    • Which surface-treated nanomaterials can be found on the EU market and in which quantities; and
    • The industrial sectors or fields of application in which these surface-treated nanomaterials are being used.

    To supplement other data gathering and help qualify data found using different sources, the survey seeks to gather people’s direct knowledge of this field. The survey is open to anyone with knowledge of the manufacturer or use of surface-treated nanomaterials within the EU. This may include manufacturers or suppliers of surface-treated nanomaterials, end users of surface-treated nanomaterials, researchers aware of surface-treated nanomaterials, or laboratories, service providers, or research and training organizations with knowledge of surface-treated nanomaterials. The survey will close October 31, 2025. Bergeson & Campbell, P.C. is a proud member of the NIA.

    Continue Reading